Tag: COVID19
McKesson signs up with Warp Speed to distribute COVID-19 shots in...
The U.S. government has placed a series of multibillion-dollar bets on potential COVID-19 vaccines. But actually getting those vaccines to patients is another story, and...
Interest in rapid Covid-19 antigen tests continues despite accuracy concerns
The governor of Ohio receiving inaccurate results from a rapid Covid-19 test has raised alarms about the tests’ reliability, but it has not necessarily...
Pharma video ads surge after initial COVID-19 slowdown, adtech company tracks significant...
After a short pause in March, pharma video ads have bounced back. Initial COVID-19 shelter-in-place advice and uncertainty dampened pharma video placement. However, video...
Samsung Biologics plots $2B ‘super plant’ as COVID-19 sends sales through...
The COVID-19 pandemic has caused shockwaves across the pharmaceutical industry with some drugmakers booking major losses in recent months. But the crisis hasn't been a...
AstraZeneca takes COVID-19 vaccine to China with BioKangtai deal for 200M-dose...
We pointed out last week that China was a notable missing element in AstraZeneca’s COVID-19 vaccine strategy, despite being the drugmaker’s second-largest market. That...
Immunology launches buoy AbbVie sales as COVID-19 swamps ex-Allergan aesthetics biz
Only months into its massive merger with Allergan, AbbVie has been forced to contend with a pandemic challenge to its brand-new aesthetics business. But...
Novavax, Fujifilm lock up supply for late-stage COVID-19 vaccine trial
Maryland biotech Novavax scored a big leg up in its hunt for a COVID-19 vaccine with a major infusion from the Trump administration this...
Synairgen says inhaled biologic lowered risk of Covid-19 worsening in hospitalized...
Shares of a small British biotechnology company soared Monday as the company announced data from an early clinical trial of an inhaled formulation of...
Lupin shuts down Indian plant after 18 workers test positive for...
India's pharmaceutical manufacturing is no stranger to the novel coronavirus after multiple waves of infections have temporarily shut down operations at a number of drugmakers'...
Moderna’s COVID-19 vaccine could cruise to $5B in sales—or more, analysts...
Moderna has never scored a commercial approval for any of its drugs or vaccines, but analysts with Jefferies think the company has a winner in...
